March 8, 2013 - Breaking News!

Biomatter accepted for indexing in Medline!

In this issue

Biomatter
Volume 3, Issue 1
January/February/March 2013
View current issue
About the cover
An illustrative model on how changes in HA regulate NSPCs in normal state and in response to injury. For more information see Moshayedi et al .
Continue reading

Biomatter Volume 3, Issue 1 includes a Special Focus on "Delivery, Retention and Engraftment of Progenitor Cells in Cell Therapy" and is Guest Edited by Dr. Glenn Prestwich

Scope of Biomatter

Recent developments in medicine have resulted in a considerable and unprecedented increase in life span. The invention of artificial implants made from biomaterials, in the 1960s, created a whole new scientific field and resulted in revolutionary technologies that strongly contributed to this increase in life expectancy. Since then, many exciting advancements shaped the modern biomaterials science, which itself originated several new fields, with biology playing a major role and where the separation between engineering and health sciences can hardly be distinguishable. Current and future research efforts in this field are believed to result in new therapeutic approaches to prevent and treat debilitating and life-threatening diseases.

Biomatter covers all types of synthetic and natural biomaterials (metals, ceramics, polymers and composites) used for biomedical applications.


Note to Potential Authors

Biomatter accepts only manuscripts that have not been previously published nor currently submitted for publication elsewhere.

All manuscripts are peer-reviewed. The guidelines for authors, sample copies and other relevant information for submitting manuscripts are available on the Guidelines for Authors webpage.

Open access charges are waived until the July/August/September 2013 issue and the final version of accepted manuscripts will be posted on the website promptly. Authors will receive a free print version of the issue containing their paper. For additional information on how to submit your manuscript please visit our guidelines.


About Biomatter

Biomatter appears as a forum to discuss and disclose the relevant advancements in the exciting and fast growing field of science and application of biomaterials. It is widely anticipated that current and future developments will soon result in products with potential to dramatically change the way in which we live, probably even with yet unimaginable future implications in healthcare.

Biomatter is an international and transdisciplinary journal for publication of peer-reviewed original research exploring the clinical and laboratory investigations in the field of science and application of biomaterials, including their physico-chemical and biological properties, as well as clinical performance, and especially those emphasizing the correlation between biomaterials structure and biological performance. The journal intends to cover all applications of biomaterials, including implantable medical devices, drug delivery systems, nanomedicine, tissue engineering and regenerative medicine.

Biomatter is intended to help researchers, academics, clinicians, industry professionals and policy makers, working in related fields of science, engineering and health sciences, to disseminate information associated to biomaterials and its related fields.

Editor-in-Chief

Pedro L. Granja
INEB—Instituto de Engenharia Biomédica
Universidade do Porto
Porto, Portugal

Email the Managing Editor, Liz Gilmer.
Print ISSN: 2159-2527
Online ISSN: 2159-2535
Abstracted/Indexed In:
Medline/Pubmed, PubMed Central

Open Access, Online Only in 2013

Biomatter is published as a fully open access, online-only journal! This allows authors free access to and distribution of published articles.

Additional information on our open access policy can be found here.

Find us on Facebook

Recommend Biomatter to your library

Click here to send a form to your librarian requesting that your institution subscribe to Biomatter.

Submit your manuscript to Biomatter

Click here to submit a manuscript to Biomatter.

Biomatter utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.

The average time from submission to acceptance (or rejection) for the current Landes Bioscience journals is one month. Once accepted, a paper is published online within three weeks.


Contents and Topics

Biomatter publishes original articles, review articles, short communications and letters to the Editor.

Biomatter covers, but is not limited to, the following topics in the context of biomaterials science:

• Advanced materials
• Animal Models
• Antimicrobial strategies
• Artificial cells, tissues and organs
• Biocompatibility studies
• Biodegradable materials
• Bioethics
• Biological response
• Biomaterials synthesis and characterization
• Biomimetic strategies
• Bioreactors
• Biosensors and screening devices
• Blood substitutes
• Cell engineering
• Cell, tissue and organ transplantation
• Clinical Trials
• Drug delivery systems
• Experimental methodologies
• Fluid dynamics, modeling and simulation
• Gene therapy
• In vitro and in vivo approaches
• Interactions between materials and cells and proteins
• Medical devices
• Nanomedicine and nanotechnology
• Regenerative medicine
• Regulatory and ethical issues
• Repair, replacement and Regeneration
• Self-Assembly
• Smart multifunctional intelligent systems
• Stem cell biology
• Structure-property-function relationship
• Surfaces, interfaces and functionalization
• Tissue engineering


Advertisements